Results
death, Stroke
STROKE
Of the 656 patients included in the IMS III trial, 131 patients could not be assessed within 90 days due to prior death. Among the remaining 525 patients, 459 (87.4%) patients had data on the blinded assessor’s designation of treatment allocation and were included in this study (Flowchart of patients included in this study. IMS: Interventional Management of Stroke.Clinical characteristics of patients included in this study versus excluded patients with unknown guess of treatment allocation.IQR: interquartile range presented as the 25th and 75th percentile; NIHSS: National Institutes of Health Stroke Scale.Baseline NIHSS score was missing for 1/459 (0.2%) patient in the group of included patients.Modified Rankin Scale score at 90 days missing for 13/66 (19.7%) patients in the group of excluded patients with missing guess of treatment allocation.